Cartesian Therapeutics Overview
Cartesian Therapeutics Discounted Cash Flow
DCF Analysis for RNAC.
Get informed when a big investor buys or sells
+ FollowFair Value
$3.75
Current Fair Value
$3.75
↓ 60.6% Downside
Overvalued by 60.6% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison